- Telehealth visits
Lauren Schumacher, MD
Psychiatry (Child and Adolescent Psychiatry)- Telehealth visits
Lauren Schumacher, MD
Psychiatry (Child and Adolescent Psychiatry)- Telehealth visits
On this page
About me
Dr. Lauren Schumacher is a psychiatrist who specializes in caring for children and adolescents. She has particular interests in anxiety and attention-deficit/hyperactivity disorder (ADHD), as well as medical education.
Schumacher earned her medical degree from Northwestern University Feinberg School of Medicine. She completed a residency in general psychiatry at Northwestern Memorial Hospital and a fellowship in child and adolescent psychiatry at UCSF.
Schumacher has presented at national conferences, and her honors include awards from several professional associations, such as the American Academy of Child and Adolescent Psychiatry, Association for Academic Psychiatry and Northern California Regional Organization of Child and Adolescent Psychiatry. She is the author of a chapter on pharmacological treatment of ADHD for an upcoming textbook on pediatric psychopharmacology (the study of how drugs affect mood, thinking and behavior).
Education & training
Board certification
- Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology
- Psychiatry, American Board of Psychiatry and Neurology
Fellowship
- Child/Adolescent Psychiatry, UCSF School of Medicine -GME
Residency
- Psychiatry, Northwestern University Medical School
Degree
- MD, Northwestern University Feinberg School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.